Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/27/2018
Novartis Loses Oncology Chief in China to Startup EpimAb
2/26/2018
MOHRSS Issues Recommended Disease Group List for Disease Group-based P...
2/26/2018
China Approved 39 Import Drugs in 2017
2/22/2018
Fosun, Arix Bioscience to Co-develop Clinical Therapies in China
2/22/2018
Tetraphase Pharma Enters into Exclusive Agreement with Everest Medicin...
2/22/2018
China's Healthcare Reforms Underscore Market Growth
2/22/2018
Merck KGaA to Build Robust Manufacturing Platform in Asia
2/22/2018
Chinese City Touted As Model for Cutting Healthcare Costs
2/22/2018
WuXi STA and Regulus Announce microRNA Development and Manufacturing C...
2/15/2018
Recent Executive Moves
2/14/2018
British Government Announces Healthcare Deals with China Worth Over GB...
2/14/2018
China's R&D Spending at Record High in 2017
2/14/2018
CFDA Releases List of Reference Formulations for Generic Drug Equivale...
2/14/2018
China Reviews Achievements of the BMI System and Medical Assistance Pr...
2/13/2018
MOLOGEN Signs Deal with ONCOLOGIE for Lead Compound Lefitolimod
2/13/2018
UK Investigators Ask for New Info from GSK Relating to Its China Corru...
2/13/2018
GNC Announces $300M Partnership with Harbin Pharma
2/13/2018
India Pharma Companies See Growing Opportunities in China following Re...
2/13/2018
GC Pharma and Lee's Pharm Enter into China Licensing Agreement for An...
2/13/2018
MSD Files NDA for Anticancer Keytruda in China
2/13/2018
CFDA Seeks Comments on Draft Document for Matters Related to Import Dr...
2/13/2018
Why China Will Capitalize on Groundbreaking Healthcare Solutions Befor...
2/13/2018
How Tencent's Medical Ecosystem Is Shaping the Future of China's Healt...
2/13/2018
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients ...
2/13/2018
Chi-Med Enrolls 527 Patients in Pivotal Phase III FALUCA Trial of Fruq...
2/13/2018
GSK's Digital Strategies for Reaching New Buyers in China
2/12/2018
The Chinese Pharmaceutical Industry: Winners and Losers 2017
2/12/2018
CFDA Publishes Its 2018 Legislation Plan
2/12/2018
CDE Solicits Comments on the General Requirements on Batch Production ...
2/11/2018
CFDA Releases List of Reference Formulations for Generic Drug Equivale...
Page:
278
/
720
Total number of articles:
21580
:
[First]
[<<]
[276]
[277]
[278]
[279]
[280]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit